Reza Shojaei: Transforming Canada’s Plasma System for Greater Resilience and Self-Sufficiency
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared a post on Linkedln:
”Canada’s plasma system is quietly undergoing one of its most important transformations in decades.
Rising demand for immunoglobulins, growing pressure on global supply chains, and years of heavy reliance on imported plasma-derived medicines have pushed plasma fractionation from a technical topic into a strategic health policy priority.
Three forces converging in 2025 were:
- accelerated growth in plasma-derived medicinal products (especially immunoglobulins).
- deliberate expansion of domestic plasma collection.
- regulatory and formulary modernization reshaping how these products are assessed, manufactured, and supplied.
This is not just a market story; it’s a resilience story.
In the latest issue of Blood and Plasma Pulse, we examine:
- where Canada’s plasma fractionation market truly stands today
- how public–private partnerships are re-engineering the supply chain
- why regulatory changes in 2025 matter far beyond compliance
- what still stands between policy ambition and domestic self-sufficiency
For healthcare leaders, regulators, biotech professionals, and anyone thinking about system sustainability, this transition will shape availability, access, and risk for years to come.”
Find more posts featuring Reza Shojae on Hemostasis Today.
-
Nov 19, 2026, 16:27263 PolyU Students and Staff Unite to Donate Blood – Hong Kong Red Cross Blood Transfusion Service
-
Nov 19, 2026, 16:16Billy Otieno: The Future of Blood Donation Lies Beyond Collection
-
Nov 19, 2026, 15:58Hema Goyal: Hematocon 2026 Bringing Together Knowledge, Innovation and Excellence in Hematology
-
Nov 19, 2026, 15:44Chukwuemeka Amarachi: Understanding Complex Blood Grouping Beyond Routine ABO And RhD Typing
-
Nov 19, 2026, 14:19Long-Read Sequencing Is Closing Diagnostic Gaps in Inherited Bleeding Disorders
-
Nov 19, 2026, 13:36Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy
-
Nov 19, 2026, 13:26M. Sekip Altunkan: The Thrombotic Risk of Andexanet Alfa
-
Nov 19, 2026, 13:18Felice Gragnano: Personalizing Antiplatelet Therapy After PCI
-
Nov 19, 2026, 13:11When Postpartum Warning Signs Are Ignored – National Blood Clot Alliance